The FDA has approved Gilead Sciences’ lenacapavir, a twice-yearly injectable medication to prevent HIV, making it the first drug approved for adults and adolescents who are at risk. The FDA’s approval ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results